ZMH Zimmer Holdings Inc. featured news, full reports, and detailed charts
Zimmer Holdings Inc. (ZMH) Wrap Up:
Zimmer Holdings, Inc. and its subsidiaries design, develop, manufacture, and market reconstructive orthopaedic implants in the Americas, Europe, and Asia Pacific. It offers joint and dental implants, spinal implants, trauma products, and related orthopaedic surgical products. Its joint reconstructive implants restore function lost due to disease or trauma in joints, such as knees, hips, shoulders, and elbows. The company’s dental reconstructive implants restore function and aesthetics in patients that have lost teeth due to trauma or disease. Its spinal implants are used by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma in various re...Zimmer Holdings Inc. (ZMH:NYSE)
Snapshot of Zimmer Holdings Inc. (ZMH)
|
OPEN
$56.61
|
PREVIOUS CLOSE
$56.86
|
|
|
DAY HIGH
$57.06
|
DAY LOW
$55.64
|
|
|
52 WEEK HIGH
11/18/09 - $58.21
|
52 WEEK LOW
03/6/09 - $30.67
|
|
|
MARKET CAP
12.1B
|
AVERAGE VOLUME 3 mo
1.7M
|
|
|
DILUTED EPS TTM
$3.33
|
SHARES OUTSTANDING
213.0M
|
|
|
ZMH Does Not Pay Dividends
|
P/E TTM
17.1x
|
|
| K = Thousands M = Millions B = Billions | ||
related news
The harsh reality check of the market crash prompted a reevaluation of strategy and the establishment of new rules to control risk
The harsh reality check of the market crash prompted a reevaluation of strategy and the establishment of new rules to control risk
Here are some investment plays that may be likely to withstand a sustained bout of falling prices
Major indexes clawed their way back from an early selloff after a weak U.S. jobs report raised fresh concerns about a recession
related news
ZMH Top Compensated Officers
Executives, Board Directors
Key developments for Zimmer Holdings Inc. (ZMH)
Zimmer Holdings Inc. - Conference Presentation Calls
Zimmer Holdings Inc. expected to Report Fiscal Year 2009 Results on January 25, 2010. This event was calculated by Capital IQ (Created on October 27, 2009).
Zimmer Holdings Inc. reported unaudited consolidated earnings results for the Third quarter and nine months ended September 30, 2009. For the quarter, the company reported net sales of $976 million, an increase of 2.4% reported and 3.6% constant currency over $952.2 million in the third quarter of 2008. Diluted earnings per share were $0.70 reported and $0.88 adjusted, a decrease of 9.3% adjusted from the prior year period. Third quarter 2008 adjusted earnings per share included a gain of $0.08 on the sale of certain equity holdings. Operating profit on an adjusted basis was $264 million flat compared to $264.8 million the prior year's third quarter. Operating profit was $204 million compared to $210.3 million a year ago. Net earnings were $149.9 million on a reported basis and $188.3 million on an adjusted basis, a decrease of 13.9% adjusted compared to net earnings of $214.7 million and adjusted earnings of $218.5 million or $0.97 per diluted share in the prior year period. Operating cash flow was $352.3 million. Earnings before tax was $199.8 million compared to $238.5 million a year ago. For the first nine months of 2009, the company's net earnings were $562.2 million on a reported basis or $2.59 per diluted share and $613.8 million or $2.82 per diluted share on an adjusted basis, a decrease of 12.3% adjusted from the prior year period. Net earnings for 2008 same period were $681.1 million or $2.97 per diluted share and adjusted earnings were $699.7 million or $3.05 per diluted share. Net sales were $2,988.1 million compared to $3,090.9 million a year ago. Operating profit was $780.3 million compared to $850.3 million a year ago. Adjusted operating profit was $858.8 million compared to $926.4 million a year ago. Earnings before tax was $768.4 million compared to $886.3 million a year ago. Net cash provided by operating activities was $732 million compared to $831.2 million a year ago. Additions to other property, plant and equipment was $76.8 million compared to $189.2 million a year ago. The company reaffirmed its sales and earnings guidance. Full year revenues for 2009 are expected to increase between 1% and 3% on a constant currency basis. Assuming foreign currency exchange rates remain consistent with current levels, the company estimates that foreign currency translation will reduce revenue for 2009 by approximately 1.6%. Full year 2009 adjusted diluted earnings per share were projected to be in a range of $3.85 to $4.00 and diluted earnings per share were projected at $3.59 to $3.74.
ZMH Competitors
| Company | Last | Change |
| DENTSPLY International Inc | $32.86 USD | -0.29 |
| Genzyme Corp | $50.05 USD | +0.42 |
| Stryker Corp | $48.73 USD | -0.09 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | ZMH | Industry Range |
| Price/Earnings | 17.1x |
|
| Price/Sales | 3.0x |
|
| Price/Book | 2.0x |
|
| Price/Cash Flow | 16.6x |
|
| TEV/Sales | 2.8x |
|
|
ZMH |
||
ZMH transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
